Health Ministry urges rational use of PPEs, says India has sufficient stock

Joint Secretary of Health Ministry also said that the Centre is augmenting the supply of PPE to states and that the states should use such gears rationally

All entry and exit points of the dargah leading up to the basti have been sealed | Photo: Dalip Kumar
Healthcare workers walking in protective suits around Delhi's Nizamuddin basto area | Photo: Dalip Kumar
BS Web TeamAgencies New Delhi
2 min read Last Updated : Apr 09 2020 | 9:32 PM IST
Thed Union Health Ministry on Thursday stressed on the rational use of personal protective equipments (PPEs) by healthcare workers who are treating coronavirus patients, amid concerns over their dwindling numbers in the country.

Joint Secretary at the Health Ministry Lav Agarwal said there is no need to panic as India has sufficient stocks of PPEs and the government is making all efforts to augment their supply further.

Addressing a daily briefing to provide updates on the COVID-19 situation, he said that 20 domestic manufacturing companies of PPEs have been developed. "Orders for 17 million PPEs have already been placed with them and supply has already begun," Agarwal said.

Since Wednesday, 540 cases of the coronavirus infection and 17 deaths have been reported, taking the total number of COVID-19 cases in India to 5,734 and death toll to 166, he said.


Over the availability of PPEs, he said, "No needs to believe any rumour or have any fear regarding the availability of such items. Our guidelines state that not only PPEs should be made available, but they should be used rationally on the basis of risk profile."

He underlined the usage of PPEs on the basis of the three defined zones --low risk, moderate risk and high risk -- and said all the components of PPEs like masks, coveralls, boots, goggles and gloves among others should be used in high risk areas like emergency, mortuary or in laboratories collecting samples.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Coronavirushealthcare technologiesHealthcare in IndiaGovernment hospitalsdoctors in Indiamedical devices industry

Next Story